Trending...
- California: Governor Newsom honors fallen CAL FIRE Engineer
- California: Governor Newsom announces appointments 1.2.2026
- JS Gallery Brings Global Voices to LA Art Show 2026 with "OFF SCRIPT" Exhibition
XTT Cell Viability Assay Kit is a colorimetric assay for studying cell proliferation and cell cytotoxicity.
MILPITAS, Calif. - Californer -- BioVision's XTT Cell Viability Assay Kit is a colorimetric assay for studying cell proliferation and cell cytotoxicity. The assay is based on the reduction of the XTT tetrazolium salt by NADH, which is produced by the mitochondrial dehydrogenase enzymes of metabolically active cells to generate an orange-colored formazan product in the cell media.
This kit can be used for studying cell proliferation in response to cytokines, nutrients, growth factors and mitogens and also for analyzing the cytotoxic and cytostatic effects of drugs, toxins, antibodies and other exogenous chemicals. In this assay, the XTT working solution is added directly to the cell culture media and is read after an incubation of 0.5-4 hr.
The measured absorbance at 475 nm is proportional to the number of viable cells. There are no steps in the assay involving changing of media or washing or addition of any solubilization reagents. The assay can detect cell numbers as high as 500,000 viable cells and as low as 1000 viable cells in each well. The presence of phenol red and/or serum in the cell growth media does not interfere with the assay. The kit provides a safe, easy-to-use, non-radioactive, high-throughput method for characterizing and screening cell viability and cytotoxicity.
More on The Californer
Figures. (A) Standard Curve of viable HeLa cells (0 to 500,000 cells/well). (B) Standard Curve of viable Jurkat cells (0 to 500,000 cells/well). (C) Cytotoxicity dose-response curve of L929 cells (2 x 104 cells/well) following 48 hr treatment with TNF-α (EC50 = 110.4 pg/ml
calculated by 4-parameter logistic curve fitting).
Storage Conditions -20ºC
USAGE For Research Use Only! Not For Use in Humans.
For more information on this Assay Kit Cat# K2108 https://bit.ly/3EfY2nF
This kit can be used for studying cell proliferation in response to cytokines, nutrients, growth factors and mitogens and also for analyzing the cytotoxic and cytostatic effects of drugs, toxins, antibodies and other exogenous chemicals. In this assay, the XTT working solution is added directly to the cell culture media and is read after an incubation of 0.5-4 hr.
The measured absorbance at 475 nm is proportional to the number of viable cells. There are no steps in the assay involving changing of media or washing or addition of any solubilization reagents. The assay can detect cell numbers as high as 500,000 viable cells and as low as 1000 viable cells in each well. The presence of phenol red and/or serum in the cell growth media does not interfere with the assay. The kit provides a safe, easy-to-use, non-radioactive, high-throughput method for characterizing and screening cell viability and cytotoxicity.
More on The Californer
- California: Governor Newsom's statement on Valero's Benicia refinery update
- California: Governor Newsom announces appointments 1.6.2026
- California: Governor Newsom lowers flags, proclaims January 7th as day of remembrance for Los Angeles fires
- Renowned Psychic Medium and Author Samantha McManus Expands Her Impact with New Offerings and Discounts
- Yunishigawa Onsen's Annual "Kamakura Festival" will be held January 30 – March 1, 2026
Figures. (A) Standard Curve of viable HeLa cells (0 to 500,000 cells/well). (B) Standard Curve of viable Jurkat cells (0 to 500,000 cells/well). (C) Cytotoxicity dose-response curve of L929 cells (2 x 104 cells/well) following 48 hr treatment with TNF-α (EC50 = 110.4 pg/ml
calculated by 4-parameter logistic curve fitting).
Storage Conditions -20ºC
USAGE For Research Use Only! Not For Use in Humans.
For more information on this Assay Kit Cat# K2108 https://bit.ly/3EfY2nF
Source: BioVision Inc
0 Comments
Latest on The Californer
- Snell & Wilmer Attorney Gregory J. Sonnenberg Named Chair of CRF-OC's Associate Board of Directors
- California: As federal aid stalls, Governor Newsom announces proposed effort to close insurance gaps for LA fire survivors, expands mortgage relief
- Southeast Ventura County YMCA Served Over 34,000 People, Provided $439,797 In Financial Ad in 2025
- BrassTranscripts Expands AI Prompt Library to 104 Templates with Sales and Pricing Calculators
- Attention ALL MEDIA COMPANIES: You are going to LOVE the ADVERTISING REVENUES from this very special kind of VALENTINE'S DAY PROMOTION!
- Custom Home Builder Connecticut Valley Homes Wins 2025 Home of the Year from the Modular Home Builders Association
- One year after LA fires: California deploys firefighting resources and advanced technology, accelerates prevention efforts
- California: Governor Newsom statement on the passing of Congressman Doug LaMalfa
- Scoop Social Co. Partners with Air Canada to Celebrate New Direct Flights to Milan with Custom Italian Piaggio Ape Gelato Carts
- Breakout Phase for Public Company: New Partnerships, Zero Debt, and $20 Million Growth Capital Position Company for 2026 Acceleration
- Japan's Patented "Hammock'n" Smartphone Band Targets Hand Fatigue From Long Phone Use
- Reditus Group Introduces A New Empirical Model for Early-Stage B2B Growth
- CCHR: Harvard Review Exposes Institutional Corruption in Global Mental Health
- NEXO, the First AI Artist From 2045, Releases Cinematic Music Video for "STACK BAGS"
- GCAC adds InJoy as Efixii NFT Coupon Reseller
- Award Winning Comedian Returns to Diamond Mountain
- IT IS WHAT IT IS by Rodrigo Angel Jimenez-Ortega
- Goatimus Launches Dynamic Context: AI Prompt Engineering Gets Smarter
- Global License Exclusive Secured for Emesyl OTC Nausea Relief, Expanding Multi-Product Growth Strategy for Caring Brands, Inc. (N A S D A Q: CABR)
- Former San Francisco Top 40 DJ Releases Candid Memoir of Radio's TOP 40-dominant years